CSPC PHARMACEUTICAL GROUP LIMITED 1093 % % 4,773,634 3,775,220 26.4% 34.3% 4,193,217 4,018,485 4.3% 10.8% 1,333,565 1,718,436 (22.4%) (17.6%) C 1,308,687 1,202,694 8.8% 15.6% 759,938 678,891 11.9% 18.9% 12,369,041 11,393,726 8.6% 15.3% 6,308,809 5,220,878 20.8% 28.3% 2,649,484 2,166,453 22.3% 29.9% 2,100,848 1,665,271 26.2% 34.0% 1
GSP 350 2
8 3
C 4
2 12,369,041 11,393,726 (6,060,232) (6,172,848) 6,308,809 5,220,878 106,970 86,561 (2,788,160) (2,266,958) (553,694) (534,881) (424,441) (339,147) 2,649,484 2,166,453 (41,711) (56,335) 141 27,559 10,663 (8,873) 3 2,635,332 2,112,049 4 (522,107) (432,423) 2,113,225 1,679,626 (658,279) (423,345) (2,773) (1,244) (661,052) (424,589) 1,452,173 1,255,037 5
2,100,848 1,665,271 12,377 14,355 2,113,225 1,679,626 1,445,017 1,244,595 7,156 10,442 1,452,173 1,255,037 5 35.25 28.18 5 35.00 27.95 6
5,415,032 5,142,767 526,712 467,785 111,785 119,388 79,232 96,080 80,089 27,586 91,732 27,986 38,706 6,332,568 5,892,312 1,933,147 1,819,228 7 1,835,266 1,877,617 8 1,215,156 1,389,493 73,570 162,212 115,986 75,179 16,419 15,057 2,477 521 606 2,875 6,202 3,234,678 2,299,468 8,427,618 7,647,539 7
9 2,937,893 2,488,645 10 100,559 392,828 1,108 1,591 657 3,060 147,769 145,063 897,777 451,966 4,084,655 3,484,261 4,342,963 4,163,278 10,675,531 10,055,590 68,865 46,322 240,380 1,010,944 174,964 185,717 484,209 1,242,983 10,191,322 8,812,607 10,569,620 9,835,299 (461,994) (1,097,244) 10,107,626 8,738,055 83,696 74,552 10,191,322 8,812,607 8
1. 11 1 16 38 16 41 10 12 28 9 1 15 1 16 2 2 1 4 4 9 1 15 15 1 10 28 3 7 4 12 4 1 2 3 4 9
2. 12,369,041 11,393,726 8 (a) (b) (c) (d) C C 8,966,851 1,333,565 1,308,687 759,938 12,369,041 12,369,041 72,689 12,621 7,688 92,998 (92,998) 8,966,851 1,406,254 1,321,308 767,626 12,462,039 (92,998) 12,369,041 2,554,555 24,493 25,726 175,254 2,780,028 2,780,028 13,005 (143,549) 2,649,484 (41,711) 27,559 2,635,332 10
C 7,793,705 1,718,436 1,202,694 678,891 11,393,726 11,393,726 55,434 4,126 8,245 67,805 (67,805) 7,793,705 1,773,870 1,206,820 687,136 11,461,531 (67,805) 11,393,726 2,030,600 189,496 (39,577) 119,853 2,300,372 2,300,372 9,807 (143,726) 2,166,453 (56,335) 141 10,663 (8,873) 2,112,049 9,679,224 8,671,612 1,228,182 1,122,154 659,305 830,673 654,555 607,443 147,775 161,844 12,369,041 11,393,726 11
3. 810,800 789,421 100,533 106,812 911,333 896,233 17,796 18,430 19,218 14,794 550,713 572,036 587,727 605,260 3,500 3,660 (26) (358) (24,976) (39,730) (13,005) (9,807) 20,572 7,012 (10,009) 1,786 32,791 36,577 (4,460) 1,972 9,024 403,140 324,505 12
4. 450,233 377,464 41,899 42,096 492,132 419,560 29,975 12,863 522,107 432,423 16.5% 25% 15% 5. 2,100,848 1,665,271 5,960,417 5,908,795 42,275 48,879 6,002,692 5,957,674 13
6. 11 10 650,212 590,802 12 11 7. 1,492,855 1,560,948 (10,423) (13,181) 1,482,432 1,547,767 150,585 176,527 51,720 62,798 46,891 29,325 103,638 61,200 1,835,266 1,877,617 90 0 90 1,357,953 1,375,675 91 180 114,647 129,875 181 365 9,832 42,217 1,482,432 1,547,767 14
8. 180 180 9. 1,113,908 752,256 547,937 441,063 86,518 113,088 79,299 70,562 678,108 678,785 126,114 109,537 109,749 111,950 115,388 145,430 80,872 65,974 2,937,893 2,488,645 0 90 1,008,024 613,893 91 180 45,290 65,471 180 60,594 72,892 1,113,908 752,256 90 10. 180 180 15
123.69 8.6% 15.3% 21.01 26.2% 34.0% 89.67 15.1% 22.2% 47.74 26.4% 34.3% 16
2014 14 76 2015 17
18
C 41.93 4.3% 10.8% 19
C C C 170 1 15 3 50 2 4 4 3+6 6 6 5 55 1 SKLB1028-1 re4 20
28 3 4 20 1 9 ANDA 4 100 3 ANDA 7 16 (IND) FDA 8,966,851 7,793,705 15.1% 3,402,190 3,600,021 (5.5)% 12,369,041 11,393,726 8.6% 2,649,484 2,166,453 22.3% 21.4% 19.0% 2,100,848 1,665,271 26.2% 17.0% 14.6% 35.25 28.18 25.1% 21
47.74 26.4% 33.1% 38.6% 21.4% 17.0% 26.2% 21.01 25.1% 35.25 29.16 22.49 49 41 108 116 2.1 2.2 11.34 32.38 23.06 11.38 14.63 21.00 8.43 10.96 0.42 8.98 2.40 16.6% 11.2% 24.3% 8.2% 67.5% 10,529 22
(i) (ii) (iii) 14 A.2.1 A.2.1 3.10A (9) (1) (5) 3.10A 23
183 183 24